A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of Intranasal Amphotericin B Suspension in Patients With Refractory, Postsurgical Chronic Sinusitis (CS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The primary objective of the study is to evaluate the safety and efficacy of Amphotericin B suspension versus placebo in the complete resolution of key chronic sinusitis symptoms during 16 weeks of treatment in patients with refractory, postsurgical CS.
Epistemonikos ID: 3d97f764210c6c17db2b4dcfb1014049d0c29035
First added on: May 04, 2024